BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1390332)

  • 41. Long-term bosentan treatment of complex congenital heart disease and Eisenmenger's syndrome.
    Díaz-Caraballo E; González-García AE; Reñones M; Sánchez-Recalde A; García-Río F; Oliver-Ruiz JM
    Rev Esp Cardiol; 2009 Sep; 62(9):1046-9. PubMed ID: 19712626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension.
    Zhang DZ; Zhu XY; Meng J; Xue HM; Sheng XT; Han XM; Cui CS; Wang QG; Zhang P
    Int J Cardiol; 2011 Mar; 147(3):433-7. PubMed ID: 20537740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anaesthesia for a patient with Down's syndrome and Eisenmenger's complex.
    Bird TM; Strunin L
    Anaesthesia; 1984 Jan; 39(1):48-50. PubMed ID: 6230022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease.
    Kotlyar E; Sy R; Keogh AM; Kermeen F; Macdonald PS; Hayward CS; McNeil KD; Celermajer DS
    Cardiol Young; 2006 Jun; 16(3):268-74. PubMed ID: 16725066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulmonary vascular resistance in complete atrioventricular septal defect. A comparison between children with and without Down's syndrome.
    Hals J; Hagemo PS; Thaulow E; Sørland SJ
    Acta Paediatr; 1993; 82(6-7):595-8. PubMed ID: 8338998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum level of soluble intercellular adhesion molecule-1 correlates with pulmonary arterial pressure in children with congenital heart disease.
    Sungprem K; Khongphatthanayothin A; Kiettisanpipop P; Chotivitayatarakorn P; Poovorawan Y; Lertsapcharoen P
    Pediatr Cardiol; 2009 May; 30(4):472-6. PubMed ID: 19184175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts.
    Webster MW; Neutze JM; Calder AL
    Pediatr Cardiol; 1992 Jul; 13(3):129-35. PubMed ID: 1318542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eisenmenger's syndrome: current management.
    Berman EB; Barst RJ
    Prog Cardiovasc Dis; 2002; 45(2):129-38. PubMed ID: 12411974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anaesthetic management of hip arthroplasty in an individual with trisomy 21 and Eisenmenger's syndrome.
    Bilak JM; Saddler J
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23580670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary artery dissection and rupture in Eisenmenger's syndrome.
    Placik B; Rodbard S; McMahon J; Swaroop S
    Vasc Surg; 1976; 10(2):72-80. PubMed ID: 952041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
    Alpert MA; Pressly TA; Mukerji V; Lambert CR; Mukerji B; Panayiotou H; Sharp GC
    Am J Cardiol; 1991 Dec; 68(17):1687-91. PubMed ID: 1746473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noninvasive assessment of pulmonary artery flow and resistance by cardiac magnetic resonance in congenital heart diseases with unrestricted left-to-right shunt.
    Bell A; Beerbaum P; Greil G; Hegde S; Toschke AM; Schaeffter T; Razavi R
    JACC Cardiovasc Imaging; 2009 Nov; 2(11):1285-91. PubMed ID: 19909932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Afterload reduction treatment for large ventricular septal defects. Dependence of haemodynamic effects of hydralazine on pretreatment systemic blood flow.
    Nakazawa M; Takao A; Shimizu T; Chon Y
    Br Heart J; 1983 May; 49(5):461-5. PubMed ID: 6838733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Down syndrome as a factor influencing hemodynamic response to pulmonary artery banding.
    Borowski A; Zeuchner M; Schickendantz S; Korb H
    Pediatr Cardiol; 1996; 17(6):375-81. PubMed ID: 8781087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Echocardiographic recognition of pulmonary arterial disease and determination of its cause.
    Come PC
    Am J Med; 1988 Mar; 84(3 Pt 1):384-94. PubMed ID: 3348242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical usefulness of the Doppler-echocardiographic method for evaluating intracardiac shunts. Combined Doppler and hemodynamic study].
    De Simone R; Iarussi D; Haberbosch W; Scialdone A; Irace L; Iacono A
    Cardiologia; 1989 Aug; 34(8):689-94. PubMed ID: 2605579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Atrial septal defect in adults: some notes on the cases with Eisenmenger's physiology (author's transl)].
    Kodama H; Nishimura M; Akita H
    Igaku Kenkyu; 1979 Sep; 49(3):139-45. PubMed ID: 547628
    [No Abstract]   [Full Text] [Related]  

  • 58. Experience with long-term nifedipine therapy in paediatric cardiological patients.
    Wimmer M; Salzer U; Schlemmer M; Marx M; Proll E
    Padiatr Padol; 1990; 25(3):181-93. PubMed ID: 2116616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Late results after repair of complete atrioventricular canal.
    Haneda K; Togo T; Sato N; Ogata H; Mohri H
    Tohoku J Exp Med; 1992 Feb; 166(2):201-8. PubMed ID: 1533066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemodynamic effects of nifedipine on secondary pulmonary hypertension in man.
    Garzaniti N; el Allaf D; D'Orio V; Cremers S; Marcelle R; Carlier J
    Acta Cardiol; 1985; 40(2):207-15. PubMed ID: 3873156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.